Extranodal NK/T-cell lymphoma, nasal type with extensive cardiopulmonary involvement by Marques-Piubelli, Mario L. et al.
Copyright: © 2021 The Authors. This is an Open Access article distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
1 Universidade de São Paulo, Faculdade de Medicina, Departamento de Patologia. São Paulo, SP, Brasil
2 The University of Texas MD Anderson Cancer Center, Department of Translational Molecular Pathology. Houston, Texas, USA
3 Universidade de São Paulo, Faculdade de Medicina, Departamento de Nefrologia. São Paulo, SP, Brasil
4 Universidade de São Paulo, Faculdade de Medicina, Departamento de Hematologia e Hemoterapia. São Paulo, SP, Brasil
5 Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia. São Paulo, SP, Brasil 
Extranodal NK/T-cell lymphoma, nasal type with extensive 
cardiopulmonary involvement
Mario L. Marques-Piubelli1,2 , Gabriel Teixeira Montezuma Sales3 ,  
Letícia Campos Clemente1 , Lidiane Inês Rosa4 Mariana Lorenzi Savioli4, 
Ricardo Pires Alvim5 , Raquel Megale Moreira3 , Fernando Pereira Frassetto1 , 
Ellen Caroline Toledo do Nascimento1 , Sheila Aparecida Coelho Siqueira1 
How to cite: Marques-Piubelli ML, Sales GTM, Clemente LC, Rosa LI, Savioli ML, Alvim RP, et al. Extranodal NK/T-cell 




Extranodal NK/T-cell lymphoma, nasal type (ENKTL-NT) is a rare type of Non-Hodgkin’s lymphoma, which usually presents 
with extranodal involvement and affects the nasal/upper aerodigestive tract in the classical presentation. Herein, we 
report the case of a 31-year-old, previously healthy, male patient diagnosed with ENKTL-NT with the involvement of the 
lung parenchyma and heart. Unfortunately, due to the rapid disease progression, the diagnosis was performed only at 
the autopsy. The authors highlight the rare clinical presentation of this type of lymphoma, as well as the challenging 
anatomopathological diagnosis in necrotic samples. 
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INTRODUCTION
Extranodal NK/T-cell lymphoma, Nasal Type 
(ENKTL-NT) is an aggressive and rare type of T-Cell 
lymphoma associated with Epstein-Barr Virus (EBV) 
infection and derived from NK cells or cytotoxic T-cells.1 
It was called “lethal midline granuloma” in the past 
due to the involvement of midline facial area. East 
Asians and Native Americans in Central and South 
America are the most commonly affected populations.2 
We report a case of a 31-year old male with ENKTL-NT 
who had an atypical clinical presentation due the 
extensive cardiopulmonary involvement.
CASE REPORT
A 31-year-old male was admitted to the emergency 
facility complaining of low back pain, daily fever, 
fatigue and hematuria over the last 10 days preceded 
by a weight loss of 8 kg for the last 2 months. He also 
presented epistaxis, hemoptysis, gross hematuria, 
dysphagia, dysphonia, and hearing loss over the last 24 
hours. His medical history included recurrent episodes 
of sinusitis treated with antibiotics.
On admission, he was pale, dehydrated, pulse 
rate was 113 beats/min and blood pressure 93 
x 52 mmHg. He also presented hypoxemic but 
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improved after oxygen supplementation. Pulmonary 
examination showed diffuse rhonchi, while the cardiac 
and abdominal examination was normal. The initial 
neurological examination showed global weakness 
(muscle strength grade IV/V) and hypotonia in all 
four limbs and areflexia. The patient also presented 
with neurosensorial deafness (VIII cranial nerve) and 
partial palsy in cranial nerves III, IV, and VI. Peripheral 
facial weakness and dysphagia were also present, 
indicating involvement of VII cranial and bulbar nerves 
(IX, X, and XI), respectively.
The initial laboratory work-up showed mild 
anemia (Hemoglobin: 11.7 g/dL, Reference Value [RV]: 
13.5 - 17.5 g/dL; Hematocrit: 31.2%, RV: 41 - 53%) and 
leukopenia (WBC: 3.140/mm3, RV: 4.500-11.000/mm3). 
Ferritin was 2800 ng/ml (RV: 20-250 ng/ml). Liver 
enzymes, lactate dehydrogenase (LDH), creatinine, 
urea, complement 3 (C3), complement 4 (C4), and 
creatine phosphokinase (CPK) were slightly increased. 
Serology for syphilis, hepatitis B and C, rheumatoid 
factor (RF), antinuclear antibody (ANA), and anti-
neutrophil cytoplasmic autoantibody (ANCA) were 
negative. Urinalysis showed hematuria.
The thoracic computed tomography (CT) showed 
multiple nodules diffusely distributed in the lungs’ 
parenchyma, with ground-glass opacity. The pleura 
and lymph nodes were not involved. The cranial CT 
showed thickening of the right ethmoid sinus wall.
A possible diagnosis of granulomatosis with 
Polyangiitis was made and therapy with piperacillin/
tazobactam, vancomycin, and methylprednisolone 
was initiated. On the third day after admission, he 
underwent to a transbronchial biopsy, which revealed 
no significant changes of the respiratory epithelium 
and tested negative for yeast and acid-fast bacilli. 
Bronchoalveolar lavage culture showed Acinetobacter 
baumanii complex. A kidney biopsy was performed 
and showed mild acute tubular necrosis and hyaline 
arteriolosclerosis. On the sixth day of hospitalization, 
the patient developed progressive shortness of breath 
and septic shock. He was submitted to endotracheal 
intubation and Amphotericin B and Colistin were 
administrated. A sinus biopsy was also performed 
and showed intense necrosis with polymorphonuclear 
inflammatory infiltrate. Bone marrow aspirate showed 
hypocellularity and the biopsy was normocellular, 
both with normal maturation of the hematopoietic 
precursors. The flow cytometry immunophenotype 
was normal, and there was no clonal rearrangement of 
the T-cell receptor (TCR) genes. The cerebrospinal fluid 
(CSF) analysis showed 180 cells (49% lymphocytes, 
44% neutrophils, 6% monocytes) with 83,200 red 
blood cells, a protein level of 271 mg/dl, and a glucose 
level of 127 mg/dl. The polymerase chain reaction (PCR) 
tests for cytomegalovirus, EBV, herpes simplex virus I/II, 
varicella-zoster virus and tuberculosis were negative, as 
well as the culture for aerobic and anaerobic bacterial. 
Concurrent flow cytometry of the CSF showed 61% NK 
lymphocytes, 36% mature T-cells and 5% polyclonal 
B-cells. The NK cells were sCD3 negative, CD16 
positive, and CD56 positive.
Due to a non-definitive diagnosis and a suspicion 
of lymphoproliferative disorder, an open lung biopsy 
was performed on the 17th day of hospitalization. 
However, hours after the procedure, the patient 
developed refractory hemodynamic instability, 
followed by death.
AUTOPSY FINDINGS
On external examination, the corpse showed pale 
mucosae and a thoracic wound with no evidence of 
postoperative complications.
There were large and bilateral pleural effusions 
of yellow citrine color. Both lungs showed multiple, 
round, fibroelastic, and whitish diffusely distributed 
nodules ranging from 0.3 cm to 2.0 cm (Figure 1A). The 
histological sections from the nodular areas showed 
the same findings as the open lung biopsy. There was 
an intense atypical lymphoid infiltrate composed of 
medium to large cells with irregular nuclei contours, 
hyperchromatic chromatin and no evident nucleoli. 
The upper airways had no significant histological 
changes and the adjacent lung parenchyma showed 
recent alveolar hemorrhage, diffuse alveolar damage, 
coagulative necrosis, pneumocytes hyperplasia, and 
microthrombi formation. The immunohistochemistry 
study was performed and showed positivity for εCD3 
(Ventana, clone 2GV6), CD30 (Ventana, clone Ber-H2), 
and CD56 (Ventana, clone 123C3) in the atypical 
cells. The association with EBV was proven by in situ 
hybridization to EBV-encoded RNA (EBER). The Ki-67 
(Ventana, clone 30-9) proliferation index in was 90%. 
The neoplastic cells were negative for CD20 (Ventana, 
clone L26), CD15 (Ventana, clone MMA), CD68 
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(Ventana, clone KP-1), and ALK-1 protein (Ventana, 
clone ALK01), supporting the diagnosis of Extranodal 
NK/T-cell lymphoma, nasal type (ENKTL-NT) (Figure 2).
The heart presented with normal valves and the 
myocardium showed pale greyish areas, which were 
more prominent in the left ventricle (Figure 1B). An 
intense interstitial infiltration of the cardiomyocytes by 
lymphoma cells was observed in these areas (Figure 3).
There was no evidence of lymphoma infiltration 
in the central nervous system (CNS), leptomeninges, 
and cranial nerves. The histological sections of the 
encephalon showed an increase of the perivascular 
space associated with perivascular hemorrhage, acute 
neuronal injury, and foci of oligodendroglial reactivity.
The liver and spleen were grossly congested. Upon 
histology, the liver showed reactive findings related to 
sepsis, such as mild portal polyclonal lymphoplasmacytic 
infiltrate. Similarly, the spleen presented with diffuse 
congestion and multiple necrotic areas, with no 
evidence of lymphoma infiltration.
The r ight kidney sections showed foci of 
hemorrhage in corticomedullary junction, early 
microscopic infarction of the cortex, and acute 
tubular necrosis. The bone marrow analysis from 
right iliac crest showed normocellular marrow (70% 
of cellularity) with trilineage cell maturation and no 
evidence of lymphoma infiltration.
According to the autopsy findings, we interpreted 
the immediate cause of death as a diffuse alveolar 
damage secondary to extensive lymphoma infiltration 
of the lung and the heart.
DISCUSSION
The case reported herein describes a young adult 
man who died due to a cardiopulmonary involvement 
by ENKTL-NT diagnosed at autopsy. This aggressive 
type of lymphoma is very rare and corresponds to 
0.2% of all Non-Hodgkin’s lymphomas and 1-2% 
of all NK/T-cell lymphomas with higher incidence in 
middle-aged males.1,2
Approximately 80% of ENKTL-NT cases occur in 
the upper aerodigestive tract, such as the nasopharynx, 
paranasal sinuses, and orbit.3 Thus, most patients have 
a clinical presentation of upper airway obstruction, 
purulent discharge, epistaxis, and facial mass.4 
Patients with involvement of these areas, regardless 
of the dissemination to other sites, are considered 
as a nasal presentation. However, the exclusive 
involvement of extranasal sites may occur in 20% 
of cases. It can present with varied clinical features, 
Figure 1. Macroscopic appearance of lung and heart. A – Gross view of the lung with multiple greyish nodular 
lesions (white arrows) in a background of a hemorrhagic parenchyma; B – Gross view of the heart shows very 
delicate irregular areas of pale and greyish color in the left ventricle (black arrow).
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making the diagnosis extremely challenging.3,5,6 
The main affected sites include the digestive tract, 
skin, adrenal glands, eyes, breast, penis, CNS, and 
testis.1,4,7-9 The bone marrow involvement is rare 
and seen in less than 20% of the patients, making 
diagnosis even more difficult.10
Figure 2. Histological appearance of a lung nodule: A - intense and diffuse hemorrhage, necrosis of the alveolar spaces, 
and diffuse lymphoid infiltrate (H&E, 40x); B - intense and atypical lymphoid infiltrate with angiocentric distribution 
(H&E, 100x); C - atypical lymphoid infiltrate composed by medium sized cells, irregular nuclei contour, condensed 
chromatin, and scant cytoplasm (H&E, 400x); D - immunohistochemistry for CD20 shows negative stain for lymphoma 
cells and positive reactive B-cells in the background (50x); E - immunohistochemistry for CD3 stain shows partial and 
strong positivity of the lymphoma cells (100x); F - immunohistochemistry for CD30 stain shows weak and partial 
positivity of the lymphoma cells (100x); G - immunohistochemistry for CD15 shows negativity of the lymphoma cells 
(100x); H - immunohistochemistry stain for CD56 shows diffuse and moderate stain of the lymphoma cells (100x); 
I - immunohistochemistry for ALK-1 protein shows negative stain of the lymphoma cells (100x); J - immunohistochemistry 
for CD68 shows negativity of the lymphoma cells and positivity of macrophages in the background (400x); K - in situ 
hybridization to EBV-encoded RNA (EBER) shows positivity in the lymphoma cells disposed in an angiocentric pattern 
(100x); L - Immunohistochemistry for Ki-67 shows high proliferation index (90%) in the lymphoma cells (100x).
Marques-Piubelli ML, Sales GTM, Clemente LC et al.
5-7Autops Case Rep (São Paulo). 2021;11:e2021246
The involvement of the heart by any type of 
lymphoma is infrequent, corresponding to 10% to 25% 
of all autopsied lymphoma cases.11 It is more common 
in T-cell lymphomas, and this hidden diagnosis is usually 
made at autopsies.11,12 Cardiopulmonary involvement 
by ENKTL-NT is also extremely rare and reported in the 
literature only as isolated case reports.8,13-17 In these 
cases, the heart involvement has been described as 
pericardial effusion, contiguous lesions or interstitial 
myocardial infiltration. The clinical manifestations of 
these cases were broad and associated with myocardial 
ischemia, valvar disease, outflow obstruction, cardiac 
tamponade, heart failure and death.
The CNS involvement is rare and occurs in less 
than 10% of all cases of ENKTL-NT.18 Due to varied 
neurological presentations, the CNS imaging evaluation 
is mandatory, and the diagnosis of paraneoplastic 
neurological syndromes should be performed as an 
exclusion diagnosis.17 The CNS involvement can be 
determined clinically or pathologically by cerebrospinal 
fluid analysis by cytology/flow cytometry, clonality or 
histologic diagnosis on brain biopsy.18 Importantly, 
the involvement of CNS in these cases is usually 
associated with more than one extranodal site and 
the prognosis is extremely poor.18 In the presented 
case, we attributed the neurological symptoms to 
a paraneoplastic syndrome. Although there was 
evidence of NK-cell expansion in the CSF, it was not 
possible to confirm clonality due the small number 
of cells in the sample. Importantly, there was no 
histological or immunophenotypically evidence of 
lymphoma infiltration of the encephalon, cranial 
nerves, leptomeninges, pons or medulla oblongata in 
the autopsy findings.
The causes of death in ENKTL-NT were recently 
explored in a recent study performed by Mei et al.19 
In this large retrospective cohort study, the authors 
included 163 patients. The cause of death was related 
to ENKTL-NT in 52.76% of the cases followed by other 
malignant neoplasia, infectious and heart diseases. The 
diagnosis at an older age and more advanced disease 
stage were related to increased mortality.
The histopathologic diagnosis of NK/T-cells 
malignancies, especially in ENKTL-NT, is challenging.1,9 
As occurred in our case, the diagnosis was delayed 
due to limited biopsies and the presence of extensive 
necrosis. Thus, the histopathological confirmation 
of NK/T-cell clonality is frequently impaired.1 The 
morphologic presentation in classical cases consists 
of a neoplastic infiltration with markedly atypia, 
pleomorphism and wide size variation. The common 
presence of a mixed inflammatory Infiltrate in 
the background may mask the diagnosis.1,2 The 
angiocentric distribution of the neoplastic cells, leading 
to vessel obstruction and necrosis, is also a consistent 
morphological finding.1,7 The NK-cells are the classical 
cells of origin; however, a T-cell phenotype has also 
been described in a minority of cases, which makes 
the diagnosis even more challenging.1-3,5,6 EBV has 
a fundamental role in the pathogenesis of ETNC-NT 
and it is present in almost all cases with a type 2 
latency.1,2,5,6 In this latency type, the virus restricts 
its gene expression and is positive only for EBNA-1, 
LMP-1, LMP-2, and EBER.20 The detection by in situ 
hybridization is more sensitive than LMP-1 in paraffin-
embedded tissue.2
As EBV is virtually present in all cases, testing is 
mandatory in all suspected cases.2,6 As considered 
Figure 3. Photomicrographs of the heart: A – Hematoxylin & Eosin (H&E) section shows cardiomyocytes with intense 
and interstitial infiltrate composed by atypical lymphoid cells of small to medium size (100x); B – in situ hybridization 
to EBV-encoded RNA (EBER) showing diffuse positivity of the atypical lymphoid cells (200x).
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during the clinical investigation of our case, the most 
important differential diagnoses are granulomatosis 
with polyangiitis, fungal infection (such as Aspergillosis), 
lymphomatoid granulomatosis, and peripheral T-cell 
lymphoma, not otherwise specified (PTCL, NOS).1,2
CONCLUSION
We interpreted this case as a rare and atypical 
clinical presentation of ENKTL-NT and highlighted 
the difficulties in performing a precise diagnosis in 
the setting of a dramatic and broad clinical course. 
Medical staff should keep in mind the investigation of 
this disease in the context of acute clinical presentation 
of heterogeneous symptoms and extranodal lesions.
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